CN102675234B - Synthetic method of sym-triazine derivative - Google Patents
Synthetic method of sym-triazine derivative Download PDFInfo
- Publication number
- CN102675234B CN102675234B CN201210139128.7A CN201210139128A CN102675234B CN 102675234 B CN102675234 B CN 102675234B CN 201210139128 A CN201210139128 A CN 201210139128A CN 102675234 B CN102675234 B CN 102675234B
- Authority
- CN
- China
- Prior art keywords
- triazine
- palladium
- reaction
- catalyst
- chloride
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- JIHQDMXYYFUGFV-UHFFFAOYSA-N 1,3,5-triazine Chemical class C1=NC=NC=N1 JIHQDMXYYFUGFV-UHFFFAOYSA-N 0.000 title claims abstract description 34
- 238000010189 synthetic method Methods 0.000 title claims abstract description 12
- 239000003054 catalyst Substances 0.000 claims abstract description 70
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 claims abstract description 48
- 238000006243 chemical reaction Methods 0.000 claims abstract description 41
- 239000003153 chemical reaction reagent Substances 0.000 claims abstract description 37
- 229910052725 zinc Inorganic materials 0.000 claims abstract description 27
- 239000011701 zinc Substances 0.000 claims abstract description 27
- 229910052763 palladium Inorganic materials 0.000 claims abstract description 24
- 239000003446 ligand Substances 0.000 claims abstract description 18
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims abstract description 17
- 150000002940 palladium Chemical class 0.000 claims abstract description 17
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 claims description 40
- XYFCBTPGUUZFHI-UHFFFAOYSA-N Phosphine Chemical compound P XYFCBTPGUUZFHI-UHFFFAOYSA-N 0.000 claims description 32
- 239000000243 solution Substances 0.000 claims description 17
- 229910000073 phosphorus hydride Inorganic materials 0.000 claims description 16
- GPIQOFWTZXXOOV-UHFFFAOYSA-N 2-chloro-4,6-dimethoxy-1,3,5-triazine Chemical compound COC1=NC(Cl)=NC(OC)=N1 GPIQOFWTZXXOOV-UHFFFAOYSA-N 0.000 claims description 14
- YNHIGQDRGKUECZ-UHFFFAOYSA-N dichloropalladium;triphenylphosphanium Chemical compound Cl[Pd]Cl.C1=CC=CC=C1[PH+](C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1[PH+](C=1C=CC=CC=1)C1=CC=CC=C1 YNHIGQDRGKUECZ-UHFFFAOYSA-N 0.000 claims description 11
- PIBWKRNGBLPSSY-UHFFFAOYSA-L palladium(II) chloride Chemical compound Cl[Pd]Cl PIBWKRNGBLPSSY-UHFFFAOYSA-L 0.000 claims description 8
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 6
- QWQOLXDTTZSJBQ-UHFFFAOYSA-M [Cl-].CC(C)[Zn+] Chemical compound [Cl-].CC(C)[Zn+] QWQOLXDTTZSJBQ-UHFFFAOYSA-M 0.000 claims description 6
- CBZGFVSHXJZAHZ-UHFFFAOYSA-M butane;chlorozinc(1+) Chemical compound [Zn+]Cl.CCC[CH2-] CBZGFVSHXJZAHZ-UHFFFAOYSA-M 0.000 claims description 6
- LIQBAAKGMWRWPS-UHFFFAOYSA-M chlorozinc(1+);methanidylbenzene Chemical compound [Zn+]Cl.[CH2-]C1=CC=CC=C1 LIQBAAKGMWRWPS-UHFFFAOYSA-M 0.000 claims description 6
- HPQUOZITTSKGPY-UHFFFAOYSA-M zinc;2h-thiophen-2-ide;chloride Chemical compound [Zn+]Cl.C=1C=[C-]SC=1 HPQUOZITTSKGPY-UHFFFAOYSA-M 0.000 claims description 6
- POILWHVDKZOXJZ-ARJAWSKDSA-M (z)-4-oxopent-2-en-2-olate Chemical compound C\C([O-])=C\C(C)=O POILWHVDKZOXJZ-ARJAWSKDSA-M 0.000 claims description 5
- 239000008346 aqueous phase Substances 0.000 claims description 5
- 239000012044 organic layer Substances 0.000 claims description 5
- YJVFFLUZDVXJQI-UHFFFAOYSA-L palladium(ii) acetate Chemical group [Pd+2].CC([O-])=O.CC([O-])=O YJVFFLUZDVXJQI-UHFFFAOYSA-L 0.000 claims description 5
- 238000010791 quenching Methods 0.000 claims description 5
- 230000000171 quenching effect Effects 0.000 claims description 5
- 238000010898 silica gel chromatography Methods 0.000 claims description 5
- 239000012043 crude product Substances 0.000 claims description 4
- NFHFRUOZVGFOOS-UHFFFAOYSA-N palladium;triphenylphosphane Chemical compound [Pd].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 NFHFRUOZVGFOOS-UHFFFAOYSA-N 0.000 claims description 4
- QFMZQPDHXULLKC-UHFFFAOYSA-N 1,2-bis(diphenylphosphino)ethane Chemical compound C=1C=CC=CC=1P(C=1C=CC=CC=1)CCP(C=1C=CC=CC=1)C1=CC=CC=C1 QFMZQPDHXULLKC-UHFFFAOYSA-N 0.000 claims description 3
- CYPYTURSJDMMMP-WVCUSYJESA-N (1e,4e)-1,5-diphenylpenta-1,4-dien-3-one;palladium Chemical compound [Pd].[Pd].C=1C=CC=CC=1\C=C\C(=O)\C=C\C1=CC=CC=C1.C=1C=CC=CC=1\C=C\C(=O)\C=C\C1=CC=CC=C1.C=1C=CC=CC=1\C=C\C(=O)\C=C\C1=CC=CC=C1 CYPYTURSJDMMMP-WVCUSYJESA-N 0.000 claims description 2
- 238000001035 drying Methods 0.000 claims description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 claims 1
- 238000000034 method Methods 0.000 abstract description 13
- 239000000758 substrate Substances 0.000 abstract description 8
- 238000003786 synthesis reaction Methods 0.000 abstract description 7
- 230000015572 biosynthetic process Effects 0.000 abstract description 6
- 238000005859 coupling reaction Methods 0.000 abstract description 6
- 125000000524 functional group Chemical group 0.000 abstract description 4
- 239000000203 mixture Substances 0.000 abstract description 4
- 239000004480 active ingredient Substances 0.000 abstract description 3
- ZOUWOGOTHLRRLS-UHFFFAOYSA-N palladium;phosphane Chemical compound P.[Pd] ZOUWOGOTHLRRLS-UHFFFAOYSA-N 0.000 abstract description 2
- JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 description 26
- -1 triazine Grignard reagents Chemical class 0.000 description 15
- 235000005074 zinc chloride Nutrition 0.000 description 13
- 239000011592 zinc chloride Substances 0.000 description 13
- VFHDCDDYMMQCBF-UHFFFAOYSA-M [Cl-].[Zn+]C1=CC=CC=C1 Chemical compound [Cl-].[Zn+]C1=CC=CC=C1 VFHDCDDYMMQCBF-UHFFFAOYSA-M 0.000 description 11
- 150000001875 compounds Chemical class 0.000 description 9
- MBOHQAALDUADLU-UHFFFAOYSA-N 2,4-dimethoxy-6-phenyl-1,3,5-triazine Chemical compound COC1=NC(OC)=NC(C=2C=CC=CC=2)=N1 MBOHQAALDUADLU-UHFFFAOYSA-N 0.000 description 8
- 150000003918 triazines Chemical class 0.000 description 7
- JYEUMXHLPRZUAT-UHFFFAOYSA-N 1,2,3-triazine Chemical group C1=CN=NN=C1 JYEUMXHLPRZUAT-UHFFFAOYSA-N 0.000 description 6
- JKAPWXKZLYJQJJ-UHFFFAOYSA-N 2,4-dichloro-6-methoxy-1,3,5-triazine Chemical compound COC1=NC(Cl)=NC(Cl)=N1 JKAPWXKZLYJQJJ-UHFFFAOYSA-N 0.000 description 6
- HTSVYUUXJSMGQC-UHFFFAOYSA-N 2-chloro-1,3,5-triazine Chemical compound ClC1=NC=NC=N1 HTSVYUUXJSMGQC-UHFFFAOYSA-N 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 230000035484 reaction time Effects 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 5
- BSHGKUVVBWAKTK-UHFFFAOYSA-M [Cl-].C(#N)C1=CC=C(C=C1)[Zn+] Chemical compound [Cl-].C(#N)C1=CC=C(C=C1)[Zn+] BSHGKUVVBWAKTK-UHFFFAOYSA-M 0.000 description 5
- PVEASFGVCLREQR-UHFFFAOYSA-M [Cl-].CC1=CC=C([Zn+])C=C1 Chemical compound [Cl-].CC1=CC=C([Zn+])C=C1 PVEASFGVCLREQR-UHFFFAOYSA-M 0.000 description 5
- 229910052799 carbon Inorganic materials 0.000 description 5
- 230000000052 comparative effect Effects 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 5
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 4
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 4
- FXIDZGCRYDTHMV-UHFFFAOYSA-M [Cl-].BrC1=CC=C(C=C1)[Zn+] Chemical compound [Cl-].BrC1=CC=C(C=C1)[Zn+] FXIDZGCRYDTHMV-UHFFFAOYSA-M 0.000 description 4
- 238000002844 melting Methods 0.000 description 4
- 230000008018 melting Effects 0.000 description 4
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 4
- 238000006467 substitution reaction Methods 0.000 description 4
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 239000012036 alkyl zinc reagent Substances 0.000 description 3
- 239000007795 chemical reaction product Substances 0.000 description 3
- 230000008878 coupling Effects 0.000 description 3
- 238000010168 coupling process Methods 0.000 description 3
- 239000001257 hydrogen Substances 0.000 description 3
- 229910052739 hydrogen Inorganic materials 0.000 description 3
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 3
- 229910052757 nitrogen Inorganic materials 0.000 description 3
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 238000001308 synthesis method Methods 0.000 description 3
- RTNUTCOTGVKVBR-UHFFFAOYSA-N 4-chlorotriazine Chemical class ClC1=CC=NN=N1 RTNUTCOTGVKVBR-UHFFFAOYSA-N 0.000 description 2
- XONKJZDHGCMRRF-UHFFFAOYSA-N 7-fluoro-1h-indole Chemical compound FC1=CC=CC2=C1NC=C2 XONKJZDHGCMRRF-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 239000007818 Grignard reagent Substances 0.000 description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 238000005481 NMR spectroscopy Methods 0.000 description 2
- WEHSIOGSZZPLIR-UHFFFAOYSA-N O=C(C=CC1=CC=CC=C1)C=CC1=CC=CC=C1.Cl.Cl Chemical compound O=C(C=CC1=CC=CC=C1)C=CC1=CC=CC=C1.Cl.Cl WEHSIOGSZZPLIR-UHFFFAOYSA-N 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 2
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 2
- DIEPMOVVIALADV-UHFFFAOYSA-M [Cl-].COC1=CC=C([Zn+])C=C1 Chemical compound [Cl-].COC1=CC=C([Zn+])C=C1 DIEPMOVVIALADV-UHFFFAOYSA-M 0.000 description 2
- UNKQVRFPUYCEJA-UHFFFAOYSA-N [Zn]CC1=CC=CC=C1 Chemical compound [Zn]CC1=CC=CC=C1 UNKQVRFPUYCEJA-UHFFFAOYSA-N 0.000 description 2
- 235000019270 ammonium chloride Nutrition 0.000 description 2
- QARVLSVVCXYDNA-UHFFFAOYSA-N bromobenzene Chemical compound BrC1=CC=CC=C1 QARVLSVVCXYDNA-UHFFFAOYSA-N 0.000 description 2
- MVPPADPHJFYWMZ-UHFFFAOYSA-N chlorobenzene Chemical compound ClC1=CC=CC=C1 MVPPADPHJFYWMZ-UHFFFAOYSA-N 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- WMKGGPCROCCUDY-PHEQNACWSA-N dibenzylideneacetone Chemical compound C=1C=CC=CC=1\C=C\C(=O)\C=C\C1=CC=CC=C1 WMKGGPCROCCUDY-PHEQNACWSA-N 0.000 description 2
- 238000000921 elemental analysis Methods 0.000 description 2
- 150000004795 grignard reagents Chemical class 0.000 description 2
- CQRPUKWAZPZXTO-UHFFFAOYSA-M magnesium;2-methylpropane;chloride Chemical compound [Mg+2].[Cl-].C[C-](C)C CQRPUKWAZPZXTO-UHFFFAOYSA-M 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- LQKPBFWXBIAJTP-UHFFFAOYSA-N triazine zinc Chemical compound [Zn].N1=NN=CC=C1 LQKPBFWXBIAJTP-UHFFFAOYSA-N 0.000 description 2
- IBXMKLPFLZYRQZ-UHFFFAOYSA-N 1,5-diphenylpenta-1,4-dien-3-one;palladium Chemical compound [Pd].[Pd].C=1C=CC=CC=1C=CC(=O)C=CC1=CC=CC=C1 IBXMKLPFLZYRQZ-UHFFFAOYSA-N 0.000 description 1
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 1
- RIRBAVAYPRSMRH-UHFFFAOYSA-N 2,4-dimethoxy-1,3,5-triazine Chemical compound COC1=NC=NC(OC)=N1 RIRBAVAYPRSMRH-UHFFFAOYSA-N 0.000 description 1
- IQHSSYROJYPFDV-UHFFFAOYSA-N 2-bromo-1,3-dichloro-5-(trifluoromethyl)benzene Chemical group FC(F)(F)C1=CC(Cl)=C(Br)C(Cl)=C1 IQHSSYROJYPFDV-UHFFFAOYSA-N 0.000 description 1
- JYPBGEPRGFCZFB-UHFFFAOYSA-N 2-chloro-4-methoxy-6-phenyl-1,3,5-triazine Chemical compound COC1=NC(Cl)=NC(C=2C=CC=CC=2)=N1 JYPBGEPRGFCZFB-UHFFFAOYSA-N 0.000 description 1
- NCMONXLWVRSCBP-UHFFFAOYSA-N 2-methoxy-1,3,5-triazine Chemical compound COC1=NC=NC=N1 NCMONXLWVRSCBP-UHFFFAOYSA-N 0.000 description 1
- BCHZICNRHXRCHY-UHFFFAOYSA-N 2h-oxazine Chemical compound N1OC=CC=C1 BCHZICNRHXRCHY-UHFFFAOYSA-N 0.000 description 1
- OMBPDLZSXJJROQ-UHFFFAOYSA-N 4-iodotriazine Chemical class IC1=CC=NN=N1 OMBPDLZSXJJROQ-UHFFFAOYSA-N 0.000 description 1
- OSDWBNJEKMUWAV-UHFFFAOYSA-N Allyl chloride Chemical compound ClCC=C OSDWBNJEKMUWAV-UHFFFAOYSA-N 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 229910021595 Copper(I) iodide Inorganic materials 0.000 description 1
- 238000006411 Negishi coupling reaction Methods 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 1
- 150000001721 carbon Chemical group 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- BZRRQSJJPUGBAA-UHFFFAOYSA-L cobalt(ii) bromide Chemical compound Br[Co]Br BZRRQSJJPUGBAA-UHFFFAOYSA-L 0.000 description 1
- LSXDOTMGLUJQCM-UHFFFAOYSA-M copper(i) iodide Chemical compound I[Cu] LSXDOTMGLUJQCM-UHFFFAOYSA-M 0.000 description 1
- 125000004093 cyano group Chemical group *C#N 0.000 description 1
- MGNCLNQXLYJVJD-UHFFFAOYSA-N cyanuric chloride Chemical compound ClC1=NC(Cl)=NC(Cl)=N1 MGNCLNQXLYJVJD-UHFFFAOYSA-N 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 125000005842 heteroatom Chemical group 0.000 description 1
- 150000002431 hydrogen Chemical class 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- 229910052751 metal Chemical group 0.000 description 1
- 239000002184 metal Chemical group 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- ANRQGKOBLBYXFM-UHFFFAOYSA-M phenylmagnesium bromide Chemical compound Br[Mg]C1=CC=CC=C1 ANRQGKOBLBYXFM-UHFFFAOYSA-M 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 238000000425 proton nuclear magnetic resonance spectrum Methods 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- WIOADUFWOUUQCV-UHFFFAOYSA-N triphenylphosphanium dichloride Chemical compound [Cl-].[Cl-].C1=CC=CC=C1[PH+](C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1[PH+](C=1C=CC=CC=1)C1=CC=CC=C1 WIOADUFWOUUQCV-UHFFFAOYSA-N 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- HANCUBNDHABGSE-UHFFFAOYSA-L zinc;oxolane;dichloride Chemical compound [Cl-].[Cl-].[Zn+2].C1CCOC1 HANCUBNDHABGSE-UHFFFAOYSA-L 0.000 description 1
Landscapes
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Catalysts (AREA)
Abstract
Description
技术领域 technical field
本发明属于均三嗪衍生物的化学合成技术领域,具体是一种利用钯盐、钯配合物以及钯盐、钯配合物与膦配体混合物作为催化剂的均三嗪衍生物的合成方法。The invention belongs to the technical field of chemical synthesis of s-triazine derivatives, in particular to a method for synthesizing s-triazine derivatives using palladium salts, palladium complexes and mixtures of palladium salts, palladium complexes and phosphine ligands as catalysts.
背景技术 Background technique
目前,对于三嗪衍生物传统的合成方法主要是通过氰基类化合物的聚合反应,但是这种方法反应时间长,底物官能团兼容性差,生成物的产率低,能够制备出的三嗪衍生物的种类较少,难度相对较大,特别是对于不对称的三嗪衍生物,使用该种方法几乎难以实现。At present, the traditional synthesis method for triazine derivatives is mainly through the polymerization reaction of cyano compounds, but this method takes a long time to react, the substrate functional group compatibility is poor, and the yield of the product is low. The triazine derivatives that can be prepared There are fewer types of compounds, and the difficulty is relatively large, especially for asymmetric triazine derivatives, it is almost difficult to use this method.
另外,也有人通过偶联反应制备三嗪衍生物,但是仅有少数报道。Menicagli等人尝试了通过格氏试剂与氯代三嗪通过偶联制备了三级烷基大位阻的三嗪衍生物。此外,Knochel等人将氯代三嗪转化为反应活性更高的碘代三嗪,通过与烷基格氏试剂交换得到三嗪格氏试剂,三嗪格氏试剂与氯化锌发生金属交换得到三嗪锌试剂,三嗪锌试剂再与溴代芳烃偶联反应制备芳基三嗪衍生物。In addition, some people have prepared triazine derivatives through coupling reactions, but there are only a few reports. Menicagli et al. tried to prepare tertiary alkyl bulky triazine derivatives by coupling Grignard reagents with chlorotriazines. In addition, Knochel et al. converted chlorotriazines to iodotriazines with higher reactivity, obtained triazine Grignard reagents by exchange with alkyl Grignard reagents, and metal exchanged triazine Grignard reagents with zinc chloride to obtain The triazine zinc reagent, the triazine zinc reagent and brominated arene coupling reaction to prepare aryl triazine derivatives.
发明人在试验与研究过程中发现上述的方法均存在以下几个问题:The inventor finds that the above-mentioned method all has the following problems in the test and research process:
1、反应底物官能团兼容性差,适用范围较小,反应产物的选择性较差;1. The functional group compatibility of the reaction substrate is poor, the scope of application is small, and the selectivity of the reaction product is poor;
2、工艺步骤繁琐、反应时间长、催化剂用量大、反应产率相对较低。2. The process steps are cumbersome, the reaction time is long, the amount of catalyst is large, and the reaction yield is relatively low.
鉴于上述缺陷的存在使得现有的三嗪衍生物的合成在工业化应用中在一定程度上受到局限,因此需要对该方面进行进一步的研究。In view of the existence of the above-mentioned defects, the synthesis of existing triazine derivatives is limited to a certain extent in industrial applications, so further research on this aspect is needed.
发明内容 Contents of the invention
为了解决现有技术中的多取代均三嗪衍生物制备过程中催化剂用量大、反应产率低、底物适用范围小、反应选择性差的问题,本发明提供了一种高效、高区域选择性的均三嗪衍生物的合成方法。In order to solve the problems of large amount of catalyst, low reaction yield, small scope of substrate application and poor reaction selectivity in the preparation process of multi-substituted s-triazine derivatives in the prior art, the present invention provides a highly efficient, high regioselective Synthetic method of s-triazine derivatives.
解决技术问题的技术方案是:均三嗪衍生物的合成方法,包括以下步骤:The technical solution for solving technical problems is: a synthetic method of s-triazine derivatives, comprising the following steps:
1)-30℃~75℃,将干燥反应器通过N2置换后依次加入氯代均三嗪、有机锌试剂以及催化剂,氯代均三嗪与有机锌试剂、催化剂的摩尔比为1:1.00~2.50:0.0025~0.20,反应1.5~4.5小时;1) From -30°C to 75°C, replace the dry reactor with N2 and add chloro-s-triazine, organic zinc reagent and catalyst in sequence. The molar ratio of chloro-s-triazine to organic zinc reagent and catalyst is 1:1.00 ~2.50: 0.0025~0.20, the reaction time is 1.5~4.5 hours;
2)向反应后的溶液中加入浓度为1mol/L的盐酸溶液至淬灭反应完全,生成的水相用萃取3次,合并有机层,干燥,浓缩,得粗品均三嗪衍生物;2) adding a hydrochloric acid solution with a concentration of 1 mol/L to the reacted solution until the quenching reaction is complete, extracting the generated aqueous phase three times, combining the organic layers, drying, and concentrating to obtain a crude s-triazine derivative;
3)粗品均三嗪衍生物经过硅胶柱色谱纯化得均三嗪衍生物;3) The crude s-triazine derivatives are purified by silica gel column chromatography to obtain s-triazine derivatives;
上述催化剂是钯盐催化剂、钯配合物催化剂、钯盐与膦配体的混合催化剂、钯配合物与膦配体的混合催化剂中的任意一种,钯盐与膦配体的混合催化剂中钯盐与膦配体的摩尔比为1:0.05~8,钯配合物与膦配体的混合催化剂摩尔比为1:0.05~8;The above-mentioned catalyst is any one of palladium salt catalyst, palladium complex catalyst, mixed catalyst of palladium salt and phosphine ligand, mixed catalyst of palladium complex and phosphine ligand, palladium salt in the mixed catalyst of palladium salt and phosphine ligand The molar ratio of the palladium complex to the phosphine ligand is 1:0.05~8, and the molar ratio of the mixed catalyst between the palladium complex and the phosphine ligand is 1:0.05~8;
上述有机锌试剂是烷基锌试剂、芳基锌试剂、杂芳基锌试剂中的一种。The above organic zinc reagent is one of alkyl zinc reagents, aryl zinc reagents and heteroaryl zinc reagents.
进一步,在步骤1)与步骤2)之间还包括步骤a)向步骤1)反应后的溶液中再加入有机锌试剂,氯代均三嗪与再次加入的有机锌试剂的摩尔比为1:1~2.5,反应1.5~4.5小时。Further, step a) is also included between step 1) and step 2) to add an organic zinc reagent to the solution after the reaction in step 1), and the molar ratio of chloro-s-triazine to the organic zinc reagent added again is 1: 1 to 2.5, the reaction time is 1.5 to 4.5 hours.
上述氯代均三嗪与第一有机锌试剂、催化剂的摩尔比在1:1.50~2.00:0.03~0.15范围较佳。The molar ratio of the above-mentioned chloro-s-triazine to the first organic zinc reagent and the catalyst is preferably in the range of 1:1.50-2.00:0.03-0.15.
上述氯代均三嗪是2-氯-4,6-二甲氧基-1,3,5-三嗪或2,4-二氯-6-甲氧基-1,3,5-三嗪。The above-mentioned chloro-s-triazine is 2-chloro-4,6-dimethoxy-1,3,5-triazine or 2,4-dichloro-6-methoxy-1,3,5-triazine .
上述钯盐与膦配体的混合催化剂中钯盐与膦配体的摩尔比为1:1~4范围内为佳,钯配合物与膦配体的混合催化剂摩尔比为1:1~4范围为佳。In the above mixed catalyst of palladium salt and phosphine ligand, the molar ratio of palladium salt to phosphine ligand is preferably in the range of 1:1-4, and the molar ratio of the mixed catalyst of palladium complex and phosphine ligand is in the range of 1:1-4 better.
上述钯盐为醋酸钯或二氯化钯或其组合。The above-mentioned palladium salt is palladium acetate or palladium dichloride or a combination thereof.
上述钯配合物为四(三苯基磷)钯、双(三苯基磷)二氯化钯、三(二亚苄基丙酮)二钯、二(乙酰丙酮)钯中的任意一种或至少两种的任意组合。The above-mentioned palladium complex is any one of tetrakis(triphenylphosphine)palladium, bis(triphenylphosphine)palladium dichloride, tris(dibenzylideneacetone)dipalladium, bis(acetylacetonate)palladium, or at least Any combination of the two.
上述膦配体为三苯基膦或1,2-双(二苯基膦)乙烷。The above-mentioned phosphine ligand is triphenylphosphine or 1,2-bis(diphenylphosphine)ethane.
上述烷基锌试剂是异丙基氯化锌或正丁基氯化锌或苄基氯化锌;The above-mentioned alkyl zinc reagent is isopropyl zinc chloride or n-butyl zinc chloride or benzyl zinc chloride;
上述芳基锌试剂是苯基氯化锌、4-甲基苯基氯化锌、4-甲氧基苯基氯化锌、4-溴苯基氯化锌、4-氰基苯基氯化锌中的任意一种;The aryl zinc reagents mentioned above are phenyl zinc chloride, 4-methylphenyl zinc chloride, 4-methoxyphenyl zinc chloride, 4-bromophenyl zinc chloride, 4-cyanophenyl zinc chloride any of zinc;
上述杂芳基锌试剂是2-噻吩基氯化锌或2-吡啶氯化锌。The aforementioned heteroaryl zinc reagent is 2-thienyl zinc chloride or 2-pyridine zinc chloride.
本发明以氯代均三嗪溶液和有机锌试剂为底物,高催化活性的钯盐催化剂、钯配合物催化剂、钯-膦配体混合催化剂为催化剂,通过氯代均三嗪与有机锌试剂的Negishi偶联反应合成了多取代的均三嗪衍生物,反应过程中催化剂使用量少、反应产率高,而且反应过程中使用的反应活性适中的烷基锌试剂和芳基锌试剂以及杂芳基锌试剂,具有官能团兼容性好,底物适用范围广,在合成不对称三嗪衍生物中具有高的反应选择性;另外反应使用廉价、易得的氯代三嗪作为有效成分,使得该方法在合成均三嗪衍生物中具有普遍适用性,成本相对较低。The present invention uses chloro-s-triazine solution and organozinc reagent as substrate, palladium salt catalyst with high catalytic activity, palladium complex catalyst, palladium-phosphine ligand mixed catalyst as catalyst, through chlorinated-s-triazine and organozinc reagent The multi-substituted s-triazine derivatives were synthesized by the Negishi coupling reaction, and the reaction process used less catalysts and high reaction yields, and the reaction process used moderately reactive alkyl zinc reagents, aryl zinc reagents and hetero The aryl zinc reagent has good functional group compatibility, a wide range of substrate applications, and high reaction selectivity in the synthesis of asymmetric triazine derivatives; in addition, the reaction uses cheap and easy-to-obtain chlorotriazine as an active ingredient, making This method has universal applicability in the synthesis of s-triazine derivatives, and the cost is relatively low.
具体实施方式 Detailed ways
下面结合实施例对本发明进一步详细说明,但本发明不限于这些实施例。The present invention will be described in further detail below in conjunction with the examples, but the present invention is not limited to these examples.
实施例1Example 1
本实施例的均三嗪衍生物的合成方法,由以下步骤实现:The synthetic method of the s-triazine derivative of the present embodiment is realized by the following steps:
步骤1:在0℃下,将装有搅拌子和橡胶塞的50mL的干燥反应管用氮气置换三次,向反应管中加入1.25mL浓度为1.20mol/L的苯基溴化镁和1.50mL浓度为1.0 mol/L的氯化锌四氢呋喃溶液,搅拌15分钟,升至室温制备成1.25ml浓度为1.2mol/L的苯基氯化锌;再向制备好的苯基氯化锌中加入175.6mg的 2-氯-4,6-二甲氧基-1,3,5-三嗪和35.1mg双(三苯基膦)二氯化钯以及26.2mg三苯基膦混合组成的催化剂,2-氯-4,6-二甲氧基-1,3,5-三嗪与苯基氯化锌与混合催化剂的摩尔比为:1:1.5:0.15,催化剂中的双(三苯基膦)二氯化钯与三苯基膦的摩尔比为1:2,室温下反应3小时;Step 1: At 0°C, a 50 mL dry reaction tube equipped with a stirring bar and a rubber stopper was replaced with nitrogen three times, and 1.25 mL of phenylmagnesium bromide with a concentration of 1.20 mol/L and 1.50 mL with a concentration of 1.0 mol/L zinc chloride tetrahydrofuran solution, stirred for 15 minutes, raised to room temperature to prepare 1.25ml of phenyl zinc chloride with a concentration of 1.2mol/L; then add 175.6mg of 2-Chloro-4,6-dimethoxy-1,3,5-triazine and 35.1 mg bis(triphenylphosphine) palladium dichloride and 26.2 mg triphenylphosphine mixed catalyst, 2-chloro - The molar ratio of 4,6-dimethoxy-1,3,5-triazine to phenylzinc chloride to the mixed catalyst is 1:1.5:0.15, bis(triphenylphosphine) dichloride in the catalyst The molar ratio of palladium chloride and triphenylphosphine is 1:2, and react at room temperature for 3 hours;
步骤2:步骤1完成后向反应管中加入浓度为1mol/L的盐酸溶液至淬灭反应完全,生成的水相用5ml乙醚萃取3次,合并有机层,加入0.5g无水硫酸钠干燥,浓缩,得到粗品均三嗪衍生物;Step 2: After step 1 is completed, add a hydrochloric acid solution with a concentration of 1mol/L to the reaction tube until the quenching reaction is complete, extract the generated aqueous phase with 5ml ether for 3 times, combine the organic layers, add 0.5g anhydrous sodium sulfate to dry, Concentrate to obtain the crude product s-triazine derivative;
步骤3:经过硅胶柱色谱纯化得215.1mg的2,4-二甲氧基-6-苯基-1,3,5-三嗪,产率为99%。Step 3: Purify by silica gel column chromatography to obtain 215.1 mg of 2,4-dimethoxy-6-phenyl-1,3,5-triazine with a yield of 99%.
对上述产物通过核磁共振仪(300兆赫兹,氘代氯仿作溶剂,四甲基氯硅烷作内标)测定了该化合物的核磁氢谱与核磁碳谱,通过元素分析仪测定了化合物中的碳、氢、氮元素的含量,通过显微熔点仪测定了化合物的熔点,具体结果如下:For the above product, the H NMR spectrum and the C NMR spectrum of the compound were measured by a nuclear magnetic resonance instrument (300 MHz, deuterated chloroform as a solvent, and tetramethylchlorosilane as an internal standard), and the carbon in the compound was determined by an elemental analyzer. , hydrogen, and nitrogen content, the melting point of the compound was measured by a micro melting point apparatus, and the specific results are as follows:
核磁氢谱(δ指化学位移,单位为百万分之一):δ 8.50 (d, J= 7.5 Hz, 2H), 7.65 - 7.36 (m, 3H), 4.13 (s, 6H)。Proton NMR spectrum (δ refers to the chemical shift, the unit is one millionth): δ 8.50 (d, J= 7.5 Hz, 2H), 7.65 - 7.36 (m, 3H), 4.13 (s, 6H).
核磁碳谱(δ指化学位移,单位为百万分之一):δ 174.92, 172.90, 135.03,132.82, 129.01, 128.48, 55.20。Carbon NMR spectrum (δ refers to the chemical shift, the unit is one millionth): δ 174.92, 172.90, 135.03, 132.82, 129.01, 128.48, 55.20.
元素分析(化合物分子式为C11H11N3O2):理论值 C 60.82, H 5.10, N 19.34;实测值 C 60.88, H 5.13, N 19.29。Elemental analysis (compound molecular formula is C 11 H 11 N 3 O 2 ): theoretical value C 60.82, H 5.10, N 19.34; measured value C 60.88, H 5.13, N 19.29.
熔点:实测值88-89℃,文献值89-90℃。Melting point: the measured value is 88-89°C, and the literature value is 89-90°C.
由上述实验数据可知,核磁氢谱中8.50和7.65 -7.36处为苯环上的五个氢化学位移,4.13处为三嗪环上甲氧基六个氢的化学位移;核磁碳谱中174.92和172.90分别为三嗪环上与甲氧基和氯连接碳原子的化学位移,135.03、132.82, 129.01、128.48为与三嗪环相连苯环上的碳位移,55.20为连接在三嗪环上甲氧基中碳原子的化学位移。通过上述元素分析测定结果表明:该化合物中碳、氢、氮元素百分含量的实测值与理论值一致。该化合物的实测熔点与文献中报道的熔点一致。由此可以得出该化合物就是目标化合物2,4-二甲氧基-6-苯基-1,3,5-三嗪。From the above experimental data, it can be seen that 8.50 and 7.65 -7.36 in the NMR spectrum are five hydrogen chemical shifts on the benzene ring, and 4.13 is the chemical shift of six hydrogens in the methoxy group on the triazine ring; 174.92 and 7.36 in the NMR carbon spectrum 172.90 is the chemical shift of the carbon atom connected to the methoxy group and chlorine on the triazine ring, respectively; 135.03, 132.82, 129.01, and 128.48 are the carbon shifts of the benzene ring connected to the triazine ring; 55.20 is the methoxy group connected to the triazine ring The chemical shift of the carbon atoms in the group. The above-mentioned elemental analysis results show that the measured values of the percentages of carbon, hydrogen and nitrogen elements in the compound are consistent with the theoretical values. The observed melting point of this compound is consistent with that reported in the literature. Thus it can be concluded that the compound is the target compound 2,4-dimethoxy-6-phenyl-1,3,5-triazine.
实施例2Example 2
本实施例的均三嗪衍生物的合成方法,由以下步骤实现:The synthetic method of the s-triazine derivative of the present embodiment is realized by the following steps:
步骤1:在-10℃下,向干燥反应器加入175.6mg的 2-氯-4,6-二甲氧基-1,3,5-三嗪、1.67ml浓度为1.2mol/L的苯基氯化锌以及由10.5mg的双(三苯基膦)二氯化钯和3.9mg三苯基膦组成的混合催化剂,2-氯-4,6-二甲氧基-1,3,5-三嗪与苯基氯化锌、混合催化剂的摩尔比为1:2:0.03,混合催化剂中双(三苯基膦)二氯化钯与三苯基膦的摩尔比为1:1,反应4小时,本步骤中其他步骤与实施例1相同。Step 1: Add 175.6mg of 2-chloro-4,6-dimethoxy-1,3,5-triazine and 1.67ml of phenyl with a concentration of 1.2mol/L to the dry reactor at -10°C Zinc chloride and a mixed catalyst consisting of 10.5 mg of bis(triphenylphosphine)palladium dichloride and 3.9 mg of triphenylphosphine, 2-chloro-4,6-dimethoxy-1,3,5- The molar ratio of triazine to phenylzinc chloride and the mixed catalyst is 1:2:0.03, and the molar ratio of bis(triphenylphosphine) palladium dichloride to triphenylphosphine in the mixed catalyst is 1:1. Reaction 4 Hour, other steps are identical with embodiment 1 in this step.
其它的步骤与实施例1相同,得到212.9mg 2,4-二甲氧基-6-苯基-1,3,5-三嗪,产率为98%。Other steps were the same as in Example 1 to obtain 212.9 mg of 2,4-dimethoxy-6-phenyl-1,3,5-triazine with a yield of 98%.
实施例3Example 3
本实施例的均三嗪衍生物的合成方法,由以下步骤实现:The synthetic method of the s-triazine derivative of the present embodiment is realized by the following steps:
步骤1:在45℃下,向干燥反应器加入175.6mg的 2-氯-4,6-二甲氧基-1,3,5-三嗪、1.46ml浓度为1.2mol/L的苯基氯化锌以及由12.6mg的双(三苯基膦)二氯化钯和18.9mg三苯基膦组成的混合催化剂,2-氯-4,6-二甲氧基-1,3,5-三嗪与苯基氯化锌、混合催化剂的摩尔比为1:1.75:0.09,混合催化剂中双(三苯基膦)二氯化钯与三苯基膦的摩尔比为1:4,反应2小时,本步骤中其他步骤与实施例1相同。Step 1: Add 175.6mg of 2-chloro-4,6-dimethoxy-1,3,5-triazine and 1.46ml of phenyl chloride with a concentration of 1.2mol/L to the dry reactor at 45°C Zinc chloride and a mixed catalyst consisting of 12.6 mg of bis(triphenylphosphine)palladium dichloride and 18.9 mg of triphenylphosphine, 2-chloro-4,6-dimethoxy-1,3,5-tri The molar ratio of oxazine to phenylzinc chloride and the mixed catalyst is 1:1.75:0.09, and the molar ratio of bis(triphenylphosphine)palladium dichloride to triphenylphosphine in the mixed catalyst is 1:4, and the reaction takes 2 hours , other steps in this step are the same as in Example 1.
其它的步骤与实施例1相同,得到206.4mg 2,4-二甲氧基-6-苯基-1,3,5-三嗪,产率为95%。Other steps were the same as in Example 1 to obtain 206.4 mg of 2,4-dimethoxy-6-phenyl-1,3,5-triazine with a yield of 95%.
实施例4Example 4
本实施例的均三嗪衍生物的合成方法,由以下步骤实现:The synthetic method of the s-triazine derivative of the present embodiment is realized by the following steps:
步骤1:在-30℃下,向干燥反应器加入175.6mg的 2-氯-4,6-二甲氧基-1,3,5-三嗪、0.84ml浓度为1.2mol/L的苯基氯化锌以及由1.7mg的双(三苯基膦)二氯化钯和0.1mg三苯基膦组成的混合催化剂,2-氯-4,6-二甲氧基-1,3,5-三嗪与苯基氯化锌、混合催化剂的摩尔比为1:1:0.0025,混合催化剂中双(三苯基膦)二氯化钯与三苯基膦的摩尔比为1:0.05,反应4.5小时,本步骤中其他步骤与实施例1相同。Step 1: Add 175.6mg of 2-chloro-4,6-dimethoxy-1,3,5-triazine and 0.84ml of phenyl with a concentration of 1.2mol/L to the dry reactor at -30°C Zinc chloride and a mixed catalyst consisting of 1.7 mg of bis(triphenylphosphine)palladium dichloride and 0.1 mg of triphenylphosphine, 2-chloro-4,6-dimethoxy-1,3,5- The molar ratio of triazine to phenyl zinc chloride and the mixed catalyst is 1:1:0.0025, the molar ratio of bis(triphenylphosphine) palladium dichloride to triphenylphosphine in the mixed catalyst is 1:0.05, and the reaction is 4.5 Hour, other steps are identical with embodiment 1 in this step.
其它的步骤与实施例1相同,得到197.7mg 2,4-二甲氧基-6-苯基-1,3,5-三嗪,产率为91%。Other steps were the same as in Example 1 to obtain 197.7 mg of 2,4-dimethoxy-6-phenyl-1,3,5-triazine with a yield of 91%.
实施例5Example 5
本实施例的均三嗪衍生物的合成方法,由以下步骤实现:The synthetic method of the s-triazine derivative of the present embodiment is realized by the following steps:
步骤1:在75℃下,向反应管中加入175.6mg的 2-氯-4,6-二甲氧基-1,3,5-三嗪、2.08ml浓度为1.2mol/L的苯基氯化锌以及由19.5mg双(三苯基膦)二氯化钯和46.6mg三苯基膦组成的混合催化剂,2-氯-4,6-二甲氧基-1,3,5-三嗪与苯基氯化锌、混合催化剂的摩尔比为1:2.5:0.2,催化剂中双(三苯基膦)二氯化钯与三苯基膦的摩尔比为1:8,反应1.5小时,本步骤中其他步骤与实施例1相同。Step 1: Add 175.6mg of 2-chloro-4,6-dimethoxy-1,3,5-triazine and 2.08ml of phenyl chloride with a concentration of 1.2mol/L to the reaction tube at 75°C Zinc chloride and a mixed catalyst consisting of 19.5 mg of bis(triphenylphosphine)palladium dichloride and 46.6 mg of triphenylphosphine, 2-chloro-4,6-dimethoxy-1,3,5-triazine The molar ratio of phenyl zinc chloride and mixed catalyst is 1:2.5:0.2, the molar ratio of bis(triphenylphosphine) palladium dichloride and triphenylphosphine in the catalyst is 1:8, and the reaction takes 1.5 hours. Other steps are identical with embodiment 1 in the step.
其它的步骤与实施例1相同,得到212.9mg 2,4-二甲氧基-6-苯基-1,3,5-三嗪,产率为98%。Other steps were the same as in Example 1 to obtain 212.9 mg of 2,4-dimethoxy-6-phenyl-1,3,5-triazine with a yield of 98%.
实施例6Example 6
上述实施例1~5的步骤1中,有效成分2-氯-4,6-二甲氧基-1,3,5-三嗪用等摩尔量的2,4-二氯-6-甲氧基-1,3,5-三嗪替换,本步骤中其他步骤与对应实施例相同。In the step 1 of the above-mentioned embodiments 1~5, the active ingredient 2-chloro-4,6-dimethoxy-1,3,5-triazine uses an equimolar amount of 2,4-dichloro-6-methoxy The base-1,3,5-triazine is replaced, and other steps in this step are the same as those in the corresponding examples.
其它的步骤与对应实施例相同。Other steps are the same as the corresponding embodiment.
实施例7Example 7
上述实施例1~6的步骤1中,混合催化剂中的双(三苯基磷)二氯化钯用等摩尔量的四(三苯基磷)钯、三(二亚苄基丙酮)二钯、二(乙酰丙酮)钯中的任意一种替换,本步骤中其他步骤与对应实施例相同。In the step 1 of above-mentioned embodiment 1~6, two (triphenylphosphine) palladium dichlorides in the mixed catalyst use four (triphenylphosphine) palladium, three (dibenzylidene acetone) dipalladium 1. Replace any one of palladium di(acetylacetonate), and other steps in this step are the same as those in the corresponding embodiment.
其它的步骤与对应实施例相同。Other steps are the same as the corresponding embodiment.
实施例8Example 8
上述实施例1~6的步骤1中,混合催化剂中的双(三苯基磷)二氯化钯用等摩尔量的醋酸钯或二氯化钯或者这两种的组合物替换,本步骤中其他步骤与对应实施例相同。In the step 1 of above-mentioned embodiment 1~6, two (triphenylphosphine) palladium dichlorides in the mixed catalyst are replaced with palladium acetate or palladium dichloride of equimolar amount or these two kinds of compositions, in this step Other steps are the same as the corresponding embodiment.
其它的步骤与对应实施例相同。Other steps are the same as the corresponding embodiment.
实施例9Example 9
上述实施例1~8的步骤1中,混合催化剂中的三苯基膦用等摩尔量的1,2-双(二苯基膦)乙烷替换,本步骤中其他步骤与对应实施例相同。In the step 1 of the above-mentioned examples 1-8, the triphenylphosphine in the mixed catalyst is replaced with an equimolar amount of 1,2-bis(diphenylphosphine)ethane, and other steps in this step are the same as those in the corresponding example.
其它的步骤与对应实施例相同。Other steps are the same as the corresponding embodiment.
实施例10Example 10
上述实施例1~9的步骤1中,混合催化剂用等摩尔量的醋酸钯催化剂或者二氯化钯催化剂替换,本步骤中其他步骤与对应实施例相同。In step 1 of the above-mentioned embodiments 1 to 9, the mixed catalyst is replaced with an equimolar amount of palladium acetate catalyst or palladium dichloride catalyst, and other steps in this step are the same as in the corresponding embodiment.
其它的步骤与对应实施例相同。Other steps are the same as the corresponding embodiment.
实施例11Example 11
上述实施例1~9的步骤1中,混合催化剂用等摩尔的由醋酸钯与二氯化钯组成的混合催化剂替换,本步骤中其他步骤与对应实施例相同。In step 1 of the above-mentioned embodiments 1 to 9, the mixed catalyst is replaced with an equimolar mixed catalyst composed of palladium acetate and palladium dichloride, and other steps in this step are the same as those in the corresponding embodiment.
其它的步骤与对应实施例相同。Other steps are the same as the corresponding embodiment.
实施例12Example 12
上述实施例1~9的步骤1中,混合催化剂用等摩尔量的四(三苯基磷)钯催化剂、双(三苯基磷)二氯化钯催化剂、三(二亚苄基丙酮)二钯催化剂、二(乙酰丙酮)钯催化剂中的任意一种替换,本步骤中其他步骤与对应实施例相同。In the step 1 of above-mentioned embodiment 1~9, four (triphenylphosphine) palladium catalysts, two (triphenylphosphine) palladium dichloride catalysts, three (dibenzylidene acetone) dichloride catalysts, three (dibenzylidene acetone) two Any one of the palladium catalyst and bis(acetylacetonate) palladium catalyst is replaced, and other steps in this step are the same as those in the corresponding embodiment.
其它的步骤与对应实施例相同。Other steps are the same as the corresponding embodiment.
实施例13Example 13
上述实施例1~9的步骤1中,混合催化剂用等摩尔量的四(三苯基磷)钯催化剂、双(三苯基磷)二氯化钯催化剂、三(二亚苄基丙酮)二钯催化剂、二(乙酰丙酮)钯催化剂中的任意两种或者三种的任意比例混合而成的混合物替换,本步骤中其他步骤与对应实施例相同。In the step 1 of above-mentioned embodiment 1~9, four (triphenylphosphine) palladium catalysts, two (triphenylphosphine) palladium dichloride catalysts, three (dibenzylidene acetone) dichloride catalysts, three (dibenzylidene acetone) two The palladium catalyst and the palladium bis(acetylacetonate)palladium catalyst are replaced by a mixture formed by mixing any two or three in any ratio, and other steps in this step are the same as those in the corresponding embodiment.
其它的步骤与对应实施例相同。Other steps are the same as the corresponding embodiment.
实施例14Example 14
上述实施例1~13的步骤1中,作为有机锌试剂的苯基氯化锌用等摩尔量的4-甲基苯基氯化锌、4-甲氧基苯基氯化锌、4-溴苯基氯化锌、4-氰基苯基氯化锌中的任意一种替换,本步骤中其他步骤与对应实施例相同。In the step 1 of above-mentioned embodiment 1~13, the phenyl zinc chloride as organozinc reagent uses equimolar amount 4-methylphenyl zinc chloride, 4-methoxyphenyl zinc chloride, 4-bromo Any one of phenyl zinc chloride, 4-cyanophenyl zinc chloride is replaced, and other steps in this step are the same as the corresponding embodiments.
其它的步骤与对应实施例相同。Other steps are the same as the corresponding embodiment.
实施例15Example 15
上述实施例1~13的步骤1中,作为有机锌试剂的苯基氯化锌用等摩尔量的异丙基氯化锌、正丁基氯化锌、苄基氯化锌中的任意一种替换,本步骤中其他步骤与对应实施例相同。In the step 1 of above-mentioned embodiment 1~13, any one in isopropyl zinc chloride, n-butyl zinc chloride, benzyl zinc chloride of equimolar amount as the phenyl zinc chloride of organozinc reagent Instead, other steps in this step are the same as those in the corresponding embodiment.
其它的步骤与对应实施例相同。Other steps are the same as the corresponding embodiment.
实施例16Example 16
上述实施例1~13的步骤1中,作为有机锌试剂的苯基氯化锌用等摩尔量的2-噻吩基氯化锌或2-吡啶氯化锌替换,本步骤中其他步骤与对应实施例相同。In the step 1 of above-mentioned embodiment 1~13, the phenyl zinc chloride as organozinc reagent is replaced with 2-thienyl zinc chloride or 2-pyridine zinc chloride of equimolar amount, other steps in this step and corresponding implementation Example is the same.
其它的步骤与对应实施例相同。Other steps are the same as the corresponding embodiment.
实施例17Example 17
上述实施例1~13的步骤1之后,进行步骤a,具体是:After step 1 of above-mentioned embodiment 1~13, carry out step a, specifically:
在步骤1)的反应液中再加入浓度为1.1mol/l的异丙基氯化锌、正丁基氯化锌、苄基氯化锌、4-甲基苯基氯化锌、4-甲氧基苯基氯化锌、4-溴苯基氯化锌、4-氰基苯基氯化锌、2-噻吩基氯化锌、2-吡啶氯化锌的任意一种作为第二次添加的有机锌试剂,2,4-二氯-6-甲氧基-1,3,5-三嗪与第二次添加的有机锌试剂的摩尔比为1:1.5,反应3小时,反应完全后进行步骤2。In the reaction solution in step 1), add isopropylzinc chloride, n-butylzinc chloride, benzylzinc chloride, 4-methylphenylzinc chloride, 4-methylzinc chloride with a concentration of 1.1mol/l Any one of oxyphenyl zinc chloride, 4-bromophenyl zinc chloride, 4-cyanophenyl zinc chloride, 2-thienyl zinc chloride, and 2-pyridine zinc chloride is used as the second addition The organozinc reagent, the molar ratio of 2,4-dichloro-6-methoxy-1,3,5-triazine to the organozinc reagent added for the second time is 1:1.5, react for 3 hours, after the reaction is complete Proceed to step 2.
其它的步骤与实施例1~13相同。Other steps are identical with embodiment 1~13.
实施例18Example 18
上述实施例1~13的步骤1之后,进行步骤a,具体是:After step 1 of above-mentioned embodiment 1~13, carry out step a, specifically:
在步骤1)的反应液中再加入浓度为1.1mol/l的异丙基氯化锌、正丁基氯化锌、苄基氯化锌、4-甲基苯基氯化锌、4-甲氧基苯基氯化锌、4-溴苯基氯化锌、4-氰基苯基氯化锌、2-噻吩基氯化锌、2-吡啶氯化锌中的任意一种作为第二次添加的有机锌试剂,2,4-二氯-6-甲氧基-1,3,5-三嗪与第二次添加的有机锌试剂的摩尔比为1:1,反应1.5小时,反应完全后进行步骤2。In the reaction solution in step 1), add isopropylzinc chloride, n-butylzinc chloride, benzylzinc chloride, 4-methylphenylzinc chloride, 4-methylzinc chloride with a concentration of 1.1mol/l Any one of oxyphenyl zinc chloride, 4-bromophenyl zinc chloride, 4-cyanophenyl zinc chloride, 2-thienyl zinc chloride, and 2-pyridine zinc chloride is used as the second The added organic zinc reagent, the molar ratio of 2,4-dichloro-6-methoxy-1,3,5-triazine to the second added organic zinc reagent is 1:1, react for 1.5 hours, and the reaction is complete Then proceed to step 2.
其它的步骤与实施例1~13相同。Other steps are identical with embodiment 1~13.
实施例19Example 19
上述实施例1~13的步骤1之后,进行步骤a,具体是:After step 1 of above-mentioned embodiment 1~13, carry out step a, specifically:
在步骤1)的反应液中再加入浓度为1.1mol/l的异丙基氯化锌、正丁基氯化锌、苄基氯化锌、4-甲基苯基氯化锌、4-甲氧基苯基氯化锌、4-溴苯基氯化锌、4-氰基苯基氯化锌、2-噻吩基氯化锌、2-吡啶氯化锌中的任意一种作为第二次添加的有机锌试剂,2,4-二氯-6-甲氧基-1,3,5-三嗪与第二次添加的有机锌试剂的摩尔比为1:2.5,反应4.5小时,反应完全后进行步骤2。In the reaction solution in step 1), add isopropylzinc chloride, n-butylzinc chloride, benzylzinc chloride, 4-methylphenylzinc chloride, 4-methylzinc chloride with a concentration of 1.1mol/l Any one of oxyphenyl zinc chloride, 4-bromophenyl zinc chloride, 4-cyanophenyl zinc chloride, 2-thienyl zinc chloride, and 2-pyridine zinc chloride is used as the second The added organic zinc reagent, the molar ratio of 2,4-dichloro-6-methoxy-1,3,5-triazine to the second added organic zinc reagent is 1:2.5, reacted for 4.5 hours, and the reaction was complete Then proceed to step 2.
其它的步骤与实施例1~13相同。Other steps are identical with embodiment 1~13.
现将Menicagli小组与Knochel等人的制备方法分别作为对比例1和对比例2与上述的本发明的实施例1和实施例6的均三嗪衍生物的合成方法进行试验对比。The preparation methods of Menicagli Group and Knochel et al. are compared with the synthesis methods of the s-triazine derivatives of Example 1 and Example 6 of the present invention as Comparative Example 1 and Comparative Example 2 respectively.
其中对比例1是Menicagli小组通过2-氯-4,6-二甲氧基-1,3,5-三嗪与芳基锌试剂或苄基锌试剂偶联合成均三嗪衍生物,合成方法如下:Wherein Comparative Example 1 is that the Menicagli group synthesizes s-triazine derivatives by coupling 2-chloro-4,6-dimethoxy-1,3,5-triazine with aryl zinc reagent or benzyl zinc reagent, and the synthetic method as follows:
步骤1:在室温下,依次向反应管中的加入1.2g(19mmol)锌粉、4.74g(6ml,115.5mmol,浓度19.2mol/L)的乙腈、172.2mg(2.25mmol)的烯丙基氯和21.7mg(0.19mmol)三氟乙酸,缓慢升温至80℃,再向反应液中加入392.6mg(2.5mmol)的溴苯,搅拌30分钟。向上述制备好的苯基溴化锌中加入543.1mg(2.5mmol)的2-氯-4,6-二甲氧基-1,3,5-三嗪和165mg(0.75mmol)的溴化钴,2-氯-4,6-二甲氧基-1,3,5-三嗪与苯基溴化锌与催化剂的摩尔比为:1:1:0.3,25℃下反应12小时;步骤2:步骤1完成后向反应管中加入浓度为1.5mol/L的氯化铵溶液至淬灭反应完全,生成的水相用5mL二氯甲烷萃取3次,合并有机层,加入1g无水硫酸镁干燥,浓缩,得到粗品均三嗪衍生物;步骤3:经过硅胶柱色谱纯化得65.2mg的2,4-二甲氧基-6-苯基-1,3,5-三嗪,产率为30%。Step 1: At room temperature, add 1.2g (19mmol) zinc powder, 4.74g (6ml, 115.5mmol, concentration 19.2mol/L) of acetonitrile, 172.2mg (2.25mmol) of allyl chloride in the reaction tube and 21.7mg (0.19mmol) of trifluoroacetic acid, slowly warming up to 80°C, and then adding 392.6mg (2.5mmol) of bromobenzene to the reaction solution, and stirring for 30 minutes. Add 543.1 mg (2.5 mmol) of 2-chloro-4,6-dimethoxy-1,3,5-triazine and 165 mg (0.75 mmol) of cobalt bromide to the above-prepared phenyl zinc bromide , the molar ratio of 2-chloro-4,6-dimethoxy-1,3,5-triazine to phenylzinc bromide and catalyst: 1:1:0.3, reacted at 25°C for 12 hours; step 2 : After step 1 is completed, add the ammonium chloride solution with a concentration of 1.5mol/L to the reaction tube until the quenching reaction is complete, extract the aqueous phase with 5mL dichloromethane for 3 times, combine the organic layers, and add 1g of anhydrous magnesium sulfate Dry and concentrate to obtain the crude product s-triazine derivative; Step 3: Purify 65.2 mg of 2,4-dimethoxy-6-phenyl-1,3,5-triazine through silica gel column chromatography, the yield is 30%.
该方法具有催化剂用量达到30%、反应时间长达12小时、产物的产率只有30%、反应的底物适用于芳基锌试剂或苄基锌试剂。The method has the advantages that the amount of the catalyst is up to 30%, the reaction time is up to 12 hours, the yield of the product is only 30%, and the reaction substrate is suitable for aryl zinc reagent or benzyl zinc reagent.
对比例2是Knochel课题组通过2,4-二氯-6-甲氧基-1,3,5-三嗪与烷基格氏试剂的偶联合成均三嗪衍生物,合成方法如下:Comparative example 2 is the synthesis of s-triazine derivatives by the Knochel research group through the coupling of 2,4-dichloro-6-methoxy-1,3,5-triazine and alkyl Grignard reagents. The synthesis method is as follows:
步骤1:在-10℃下,依次向干燥,氮气置换的反应管中加入180.0mg(1.0mmol)的2,4-二氯-6-甲氧基-1,3,5-三嗪和38.1mg(0.2mmol)的碘化亚铜催化剂,搅拌30分钟后,缓慢的向上述反应液中加入3.5mL浓度为1.0mol/L的叔丁基氯化镁的四氢呋喃溶液,2,4-二氯-6-甲氧基-1,3,5-三嗪与叔丁基氯化镁与催化剂的摩尔比为:1:3.5:0.2,0℃下反应12小时;步骤2:步骤1完成后向反应管中加入浓度为1.5mol/L的氯化铵溶液至淬灭反应完全,生成的水相用5mL乙酸乙酯萃取3次,合并有机层,加入1.5g无水硫酸镁干燥,浓缩,得到粗品均三嗪衍生物;步骤3:经过硅胶柱色谱纯化得66.5mg的2-氯-4-甲氧基-6-苯基-1,3,5-三嗪和,52.7mg的2-氯-4,6-二苯基-1,3,5-三嗪和,其中单取代与双取代的摩尔比为:60:40,总产率为50%。Step 1: Add 180.0 mg (1.0 mmol) of 2,4-dichloro-6-methoxy-1,3,5-triazine and 38.1 mg (0.2mmol) cuprous iodide catalyst, after stirring for 30 minutes, slowly add 3.5mL tetrahydrofuran solution of tert-butylmagnesium chloride with a concentration of 1.0mol/L to the above reaction solution, 2,4-dichloro-6 - The molar ratio of methoxy-1,3,5-triazine to tert-butylmagnesium chloride to the catalyst is 1:3.5:0.2, react at 0°C for 12 hours; step 2: after step 1 is completed, add Ammonium chloride solution with a concentration of 1.5 mol/L until the quenching reaction is complete, the resulting aqueous phase is extracted 3 times with 5 mL of ethyl acetate, the organic layers are combined, dried by adding 1.5 g of anhydrous magnesium sulfate, and concentrated to obtain the crude product s-triazine Derivatives; Step 3: 66.5 mg of 2-chloro-4-methoxy-6-phenyl-1,3,5-triazine and 52.7 mg of 2-chloro-4,6 were purified by silica gel column chromatography -Diphenyl-1,3,5-triazine and wherein the molar ratio of mono-substitution and di-substitution is: 60:40, and the total yield is 50%.
该方法中催化剂的用量达20%,反应时间长达12小时,产率也只有50%,反应使用的格氏试剂局限于烷基格氏试剂,反应产物中单取代和双取代的摩尔比为:1.5:1,选择性差。In this method, the consumption of catalyzer reaches 20%, and the reaction time reaches 12 hours, and productive rate also only has 50%, and the Grignard reagent used in reaction is limited to alkyl Grignard reagent, and the mol ratio of single substitution and double substitution in the reaction product is : 1.5:1, poor selectivity.
实验结果如下:The experimental results are as follows:
表1现有技术与本发明的均三嗪衍生物的合成方法对比The prior art of table 1 compares with the synthetic method of the s-triazine derivative of the present invention
上表中2-氯-4,6-二甲氧基-1,3,5-三嗪反应生成的产物为2,4-二甲氧基-6-苯基-1,3,5-三嗪;2,4-二氯-6-甲氧基-1,3,5-三嗪反应生成的单取代产物是2-氯-4-甲氧基-6-苯基-1,3,5-三嗪,双取代产物是2-甲氧基-4,6-二苯基-1,3,5-三嗪。The reaction product of 2-chloro-4,6-dimethoxy-1,3,5-triazine in the above table is 2,4-dimethoxy-6-phenyl-1,3,5-tri Azine; -triazine, the disubstituted product is 2-methoxy-4,6-diphenyl-1,3,5-triazine.
由上表的结果可知,本发明所使用催化剂的量少,反应时间短,较对比例1和2的产率高,而且本发明的单取代产物:双取代产物值为100:0,与现有技术相比其选择性更好。As can be seen from the results of the above table, the amount of catalyst used in the present invention is less, the reaction time is short, and the yield is higher than that of Comparative Examples 1 and 2, and the mono-substituted product of the present invention: the double-substituted product value is 100:0, which is similar to that of the present invention. There are techniques better than its selectivity.
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210139128.7A CN102675234B (en) | 2012-05-07 | 2012-05-07 | Synthetic method of sym-triazine derivative |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210139128.7A CN102675234B (en) | 2012-05-07 | 2012-05-07 | Synthetic method of sym-triazine derivative |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102675234A CN102675234A (en) | 2012-09-19 |
CN102675234B true CN102675234B (en) | 2015-01-07 |
Family
ID=46807853
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210139128.7A Expired - Fee Related CN102675234B (en) | 2012-05-07 | 2012-05-07 | Synthetic method of sym-triazine derivative |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102675234B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106784887B (en) * | 2016-12-08 | 2019-11-05 | 湘潭大学 | As the cyclopolymer of s-triazine containing aryl as catalyst prepared by presoma and its preparation method and application |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1970552A (en) * | 2005-11-25 | 2007-05-30 | 中国科学院上海药物研究所 | Substituted[1,3,5] triazine compound, its preparing process and its application |
-
2012
- 2012-05-07 CN CN201210139128.7A patent/CN102675234B/en not_active Expired - Fee Related
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1970552A (en) * | 2005-11-25 | 2007-05-30 | 中国科学院上海药物研究所 | Substituted[1,3,5] triazine compound, its preparing process and its application |
Non-Patent Citations (2)
Title |
---|
Cobalt-Catalyzed Arylation or Benzylation of 2-Chloro-4,6-dimethoxy-1,3,5-triazine;Begouin J. M. et al.;《Synlett》;20091023(第19期);第3192-3194页 * |
Organometallic alkylation of 2-chloro-4,6-dimethoxy-1,3,5-triazine: a study;Samaritani S. et al.;《Tetrahedron》;20050223;第61卷;第4475-4483页 * |
Also Published As
Publication number | Publication date |
---|---|
CN102675234A (en) | 2012-09-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101265253B (en) | Heterogeneous catalytic synthesis method of cyclic carbonate | |
CN103408445B (en) | A kind of arylamine derivative and preparation method thereof | |
CN103232365B (en) | Schiff base compound, and synthesis method and application thereof | |
WO2019104841A1 (en) | Method for preparing cyclic carbonate | |
CN102503966B (en) | Schiff-base ligand-based rare-earth metal complex, preparation method and applications | |
CN104151364A (en) | O-pyrazolyl phenyl functionalized nitrogen heterocyclic carbene palladium complex and preparation method and application thereof | |
CN107652206A (en) | A kind of big steric hindrance α diimine compounds of acenaphthenyl skeleton and its synthetic method | |
CN101219399A (en) | Preparation method and application of nitrogen heterocyclic carbene metal palladium catalyst | |
CN106278847B (en) | Monofluoroalkyl-containing compound, its preparation method and application | |
CN104628643B (en) | A kind of preparation method of isoquinolinone and derivative thereof | |
CN111233752A (en) | Method for decarboxylation in situ methylation of alkyl active carboxylate | |
CN102675234B (en) | Synthetic method of sym-triazine derivative | |
CN101591360B (en) | Ionic liquid type monophosphine monoimidazolium salt nickel (II) complex and preparation and application thereof | |
Munir et al. | Synthesis of new Pro-PYE ligands as co-catalysts toward Pd-catalyzed Heck–Mizoroki cross coupling reactions | |
CN109694350B (en) | A kind of compound containing fluoromethyl group and preparation method thereof | |
CN106749411A (en) | A kind of o-phenanthroline tetradentate ligandses and preparation method and application | |
CN113200812B (en) | 1,3,5-trisubstituted aryl compound synthesis method | |
CN105541717A (en) | Novel pyrazole compound and synthesis method | |
CN111909217B (en) | Bis(di-tert-butyl-4-dimethylaminophenylphosphine)tetrabromobispalladium(II) compound and its preparation method and use | |
CN105209435A (en) | Pyridine- or pyrazine-containing compounds | |
JP4413507B2 (en) | Pincer metal complex, method for producing the same, and pincer metal complex catalyst | |
CN106366069A (en) | Preparation method of N-heteroaryl carbazole compounds | |
Zhu et al. | Two Gd (III) coordination polymers based on a flexible tricarboxylate: syntheses, structures, luminescence and catalytic properties | |
Hu | Cross coupling of non-activated alkyl halides by a nickel pincer complex | |
CN114602558B (en) | Metallic iridium photocatalyst and preparation method and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20150107 Termination date: 20170507 |